https://www.selleckchem.com/pr....oducts/SB-525334.htm
Among patients within the ELN2017 intermediate- and adverse-risk groups, RFS and OS were significantly better for patients with IDH2-R172K compared to wtIDH, providing evidence that AML with IDH2-R172K could be a distinct entity with a specific co-mutation pattern and favorable outcome. In summary, the presented data from a large cohort of IDH1/2 mutant AML patients indicate novel and clinically relevant findings for the most common IDH-mutation subtypes.The Rockwood Clinical Frailty Scale is a validated rapid assessment of frailty ph
Curtir
Comentario
Compartilhar
